Literature DB >> 7576404

Association between salt sensitivity and insulin concentrations in patients with hypertension.

I Zavaroni1, P Coruzzi, L Bonini, G L Mossini, L Musiari, P Gasparini, M Fantuzzi, G M Reaven.   

Abstract

This study was performed in 28 patients with mild to moderate hypertension, classified as being either salt sensitive or salt resistant on the basis of the percent decrement in mean arterial blood pressure (MAP) seen 7 days after daily salt intake was decreased from 220 to 30 mmol/L. Ten patients had a percent decrease of MAP > 10% and were defined as being salt sensitive. Salt resistance was defined as a percent decrease in MAP of < 3% and eight patients satisfied this criterion. Both plasma glucose and insulin concentrations following a 75-g oral glucose challenge were significantly higher after the high-salt diet in the salt-sensitive patients. Furthermore, there were correlations of marginal statistical significance between the decrease in MAP after the low-salt diet and the plasma glucose (r = 0.32, P < .10) and insulin (r = 0.38, P < .06) responses to oral glucose. These data are consistent with the view that there is an association between resistance to insulin-mediated glucose disposal and salt sensitivity in patients with high blood pressure.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7576404     DOI: 10.1016/0895-7061(95)00152-F

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  10 in total

Review 1.  The link between the renin-angiotensin-aldosterone system and renal injury in obesity and the metabolic syndrome.

Authors:  Tina Thethi; Masumi Kamiyama; Hiroyuki Kobori
Journal:  Curr Hypertens Rep       Date:  2012-04       Impact factor: 5.369

2.  Ovarian hypertension: polycystic ovary syndrome.

Authors:  Rhonda Bentley-Lewis; Ellen Seely; Andrea Dunaif
Journal:  Endocrinol Metab Clin North Am       Date:  2011-06       Impact factor: 4.741

3.  Effect of low salt diet on insulin resistance in salt-sensitive versus salt-resistant hypertension.

Authors:  Rajesh Garg; Bei Sun; Jonathan Williams
Journal:  Hypertension       Date:  2014-09-02       Impact factor: 10.190

Review 4.  Salt, aldosterone, and insulin resistance: impact on the cardiovascular system.

Authors:  Guido Lastra; Sonal Dhuper; Megan S Johnson; James R Sowers
Journal:  Nat Rev Cardiol       Date:  2010-08-10       Impact factor: 32.419

5.  Cardiovascular Risk Factors in Bulgarian Patients with Polycystic Ovary Syndrome and/or Obesity.

Authors:  Antoaneta Gateva; Zdravko Kamenov
Journal:  Obstet Gynecol Int       Date:  2012-01-04

6.  Association between insulin resistance and left ventricular hypertrophy in asymptomatic, Black, sub-Saharan African, hypertensive patients: a case-control study.

Authors:  Bernard Kianu Phanzu; Aliocha Nkodila Natuhoyila; Eleuthère Kintoki Vita; Jean-René M'Buyamba Kabangu; Benjamin Longo-Mbenza
Journal:  BMC Cardiovasc Disord       Date:  2021-01-02       Impact factor: 2.298

Review 7.  Salt-Sensitivity of Blood Pressure and Insulin Resistance.

Authors:  Lale A Ertuglu; Fernando Elijovich; Cheryl L Laffer; Annet Kirabo
Journal:  Front Physiol       Date:  2021-12-13       Impact factor: 4.566

Review 8.  Cardiometabolic aspects of polycystic ovarian syndrome.

Authors:  Li Wei Cho; Harpal S Randeva; Stephen L Atkin
Journal:  Vasc Health Risk Manag       Date:  2007

Review 9.  Obstetric complications in women with IVF conceived pregnancies and polycystic ovarian syndrome.

Authors:  Sunita R Tandulwadkar; Pooja A Lodha; Nirzari T Mangeshikar
Journal:  J Hum Reprod Sci       Date:  2014-01

10.  Pregnancy Outcomes of Women With Polycystic Ovary Syndrome for the First In Vitro Fertilization Treatment: A Retrospective Cohort Study With 7678 Patients.

Authors:  Su Liu; Meilan Mo; Shan Xiao; Longfei Li; Xiuyu Hu; Ling Hong; Linlin Wang; Ruochun Lian; Chunyu Huang; Yong Zeng; Lianghui Diao
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-25       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.